Di Rosa A E, Morgante L, Meduri M, Musolino R, Leggiadro N, Coraci M, Crisafulli A, Di Perri R
Institute of Neurological, University of Messina, Italy.
Funct Neurol. 1987 Jan-Mar;2(1):47-50.
Forty-two elderly patients affected by a generic cerebrovascular disease developed a parkinsonian syndrome after prolonged treatment with flunarizine. Following flunarizine withdrawal the extrapyramidal symptomatology remitted slowly and progressively for 12 weeks, leading to the belief that the observed parkinsonian syndrome is directly linked to the chronic use of this compound. Similar side effects are not described in young populations, however. A periodic flunarizine discontinuation in chronically treated subjects aged 65 or more is suggested.
